Single monosomy as a relatively better survival factor in acute myeloid leukemia patients with monosomal karyotype
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q2Scopus Q2
- 저널
- BLOOD CANCER JOURNAL5 · 2015
- 피인용
- Web of Science 15
- JCR IF
- JCR 2014 3.467
- ISSN
- 2044-5385
저자
- Jang, J. E.제1저자연세대학교, Coll Med, Severance Hosp, KO
- Min, Y. H.연세대학교, Coll Med, Severance Hosp, KO
- Yoon, J.가톨릭대학교, Seoul St Marys Hosp, Canc Res Inst, KO
- Kim, I.서울대학교, Coll Med, Dept Internal Med, KO
- Lee, J-H울산대학교, Dept Hematol, Asan Med Ctr, KO
- Jung, C. W.성균관대학교, Sch Med, Samsung Med Ctr, KO
- 신호진부산대학교, 의과대학, 의학과, 내과학교실, KO
- Lee, W. S.인제대학교, Dept Hematooncol, Dept Internal Med, KO
- Lee, J. H.가천대학교, Gil Med Ctr, Dept Internal Med, KO
- Hong, D-S순천향대학교, Div Hematol & Oncol, Dept Internal Med, KO
- Kim, H-J가톨릭대학교, Dept Hematol & Oncol, Hwasun Hosp, KO
- Kim, H-JCatholic Inst Visual Sci, 의학과
- Park, S.서울대학교, Coll Med, Dept Internal Med, KO
- Lee, K-H울산대학교, Dept Hematol, Asan Med Ctr, KO
- Jang, J. H.성균관대학교, Sch Med, Samsung Med Ctr, KO
- 정주섭부산대학교, 의과대학, 의과학과, KO
- Lee, S. M.인제대학교, Dept Hematooncol, Dept Internal Med, KO
- Park, J.가천대학교, Gil Med Ctr, Dept Internal Med, KO
- Park, S. K.순천향대학교, Div Hematol & Oncol, Dept Internal Med, KO
- Ahn, J-S전남대학교, Dept Hematol & Oncol, Hwasun Hosp, KO
- Min, W-S교신저자가톨릭대학교, Seoul St Marys Hosp, Canc Res Inst, KO
- Cheong, J-W연세대학교, Coll Med, Severance Hosp, KO
초록
Monosomal karyotype (MK) defined by either >= 2 autosomal monosomies or single monosomy with at least one additional structural chromosomal abnormality is associated with a dismal prognosis in patients with acute myeloid leukemia (AML). It was detected in 174 of 3041 AML patients in South Korean Registry. A total of 119 patients who had received induction therapy were finally analyzed to evaluate the predictive factors for a positive prognosis. On multivariate analysis, single monosomy, the absence of abn(17p), >= 10% of cells with normal metaphase and the achievement of a complete remission (CR) after induction therapy were significant factors for more favorable outcomes. Especially, single monosomy remained as a significantly independent prognostic factor for superior survival in both patients who received allogeneic hematopoietic stem cell transplantation (allo-HSCT) in CR and who did not. Allo-HSCT in CR improved overall survival significantly only in patients with a single monosomy. Our results suggest that MK-AML may be biologically different according to the karyotypic subtype and that allo-HSCT in CR should be strongly recommended to patients with a single monosomy. For other patients, more prudent treatment strategies should be examined. Furthermore, the biological mechanism by which a single monosomy influences survival should be investigated.
키워드
STEM-CELL TRANSPLANTATIONCOMPLEX ABERRANT KARYOTYPEPROGNOSTIC IMPACTPOOR-PROGNOSISMYELODYSPLASTIC SYNDROMEPOSTREMISSION THERAPYTP53 MUTATIONDELETIONADULTSUBGROUP
식별자
- WoS UID
- 000368920300008



로그인
연구물 목록으로